The weekly federal-spending brief. One email a Sunday. Free. No tracking.
The BuildoutBeta
Awards/COOPERATIVE AGREEMENT (B)

$136,265,880

Department of Health and Human Services·National Institutes of Health

to TRUSTEES OF BOSTON UNIVERSITY

biotechactive
ACTION DATE2026-04-22·SOURCEUSASPENDING·SOURCE IDASST_NON_UC7AI095321_075
Award description

NATIONAL EMERGING INFECTIOUS DISEASES LABORATORIES OPERATIONS

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high
In plain English

Operates the National Emerging Infectious Diseases Laboratories at Boston University for research on dangerous pathogens.

Sub-sectors
infectious-disease-researchnih-research-grantbsl4-laboratory
Why this matters

Critical biosafety infrastructure for studying high-threat infectious diseases and developing countermeasures to emerging pandemic threats.

Supply-chain signal

Drives demand for specialized biosafety equipment, containment systems, diagnostic reagents, and trained personnel in biodefense sectors.

U.S.–China competition angle

U.S. maintains advanced BSL-4 laboratory capacity for pandemic preparedness and biodefense, an area of strategic competition with China.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002218.

Period of performance
Start
2014-06-01
End
2026-10-31
Status
activein 167 days
Other awards from this recipient
Sources

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.